Institutional Ownership Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY). We have compiled data on the 87 institutions that hold shares in the stock, with a total of 51.9 Million shares, which have been reported (via 13F filing form) to have a value of $208 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
2,001
shares
|
$8,004
0.0% of portfolio
|
Q2 2025
Reduced 96.79%
|
|
|
Gf Fund Management Co. Ltd.
Guangzhou, F4 |
Jul 21, 2025 Q2 2025 |
1,544
shares
|
$6,176
0.0% of portfolio
|
Q1 2025
Added 14.46%
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
1,390
shares
|
$5,560
0.0% of portfolio
|
Q2 2025
Reduced 96.36%
|
|
|
Russell Investments Group, Ltd.
|
Aug 13, 2025 Q2 2025 |
1,035
shares
|
$4,140
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Eukles Asset Management
|
Aug 06, 2025 Q2 2025 |
1,000
shares
|
$4,000
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Nisa Investment Advisors, LLC
|
Jul 31, 2025 Q2 2025 |
919
shares
|
$3,676
0.0% of portfolio
|
Q2 2025
Added 158.87%
|
|
|
Ever Source Wealth Advisors, LLC
|
Aug 13, 2025 Q2 2025 |
270
shares
|
$1,080
0.0% of portfolio
|
Q2 2025
Reduced 31.65%
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Aug 07, 2025 Q2 2025 |
34
shares
|
$136
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Ifp Advisors, Inc
|
Jul 24, 2025 Q2 2025 |
0
shares
|
$0
0.0% of portfolio
|
Q2 2025
Closed
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|